Customs and Border Protection seizes $86.5 million in illegal vapes
(The Center Square) – U.S. Customs and Border Protection announced the seizure Wednesday of 4.7 million illegal e-cigarette products with an estimated retail value of $86.5 million – the largest-ever seizure of its kind.
The seizures were part of a joint federal operation in Chicago. Nearly all the illegal shipments uncovered by the operation originated in China. FDA and CBP officials found that many shipments contained vague and misleading product descriptions with incorrect values – an apparent attempt to evade import duties and the review of products for import safety concerns.
“We will never allow foreign actors to threaten the health of America’s children,” said HHS Secretary Robert F. Kennedy Jr. “Today we took decisive action to protect kids from illegal vape products.”
The seizure is part of a broader strategy to curb childhood vaping. Federal authorities are also going after the practice of “port shopping,” where importers repeatedly move products between ports to avoid taxes and scrutiny.
“The FDA and our federal partners are taking strong actions to shore up America’s borders and stop the flow of illegal vaping products into our country,” said FDA Commissioner Dr. Marty Makary. “Americans – especially our children – should not be using potentially dangerous, addicting products that have been snuck into the U.S. If a product has not been authorized by the FDA, CBP will seize, detain or destroy it.”
In total this year, the FDA and CBP have stopped more than 6 million unauthorized e-cigarettes worth over $120 million from entering the country.
All e-cigarette products seized in this operation lacked the mandatory premarket authorization orders from the FDA and therefore cannot be legally marketed or distributed in the U.S.
In addition to the seizures, the FDA contacted 37 importers and import entry filers regarding their actions.
“These firms were responsible for importing these illegal e-cigarettes and were advised that it is a federal crime to make false statements or entries to the U.S. government,” according to the federal agency. “The FDA reminded the firms of their responsibility to ensure the products they import comply with U.S. requirements and that their import entries must contain complete and accurate information moving forward.”
The FDA requested the firms to respond to the letters within 30 days with the requested information.
Latest News Stories
U.S. to build nuclear reactor on Moon by 2030, cost unknown
WATCH: Gov. Polis calls out Republicans in State of the State
Republican senators introduce bill to address childcare, immigration fraud
More than $1 billion spent on noncitizen hospital costs in fiscal 2025
IL Senate GOP: Pritzker, not Trump, raised power bills
SC weighs whether Amazon must pay workers for mandatory COVID screenings
Federal judge allows New York wind project to proceed
Goodlander faces federal probe over ‘illegal orders’ video
Pennsylvania lawmakers criticize violent ICE encounters
WATCH: Tax increase talk at Statehouse; Bost’s election lawsuit against Illinois wins standing
Illinois Quick Hits: Indiana governor ‘working hard’ to attract Bears
Meeting Summary and Briefs: Capital Improvements & IT Committee for January 6, 2026